FIELD: organic chemistry.
SUBSTANCE: invention relates to the use of ethyl 5-methyl-2-(((2Z,3Z)-3-(2-oxo-2-phenylidene)-3,4-dihydro-2H-benzo[b][1,4]thiazin-2-ylidene)amion)thiophene-3-caroxylate (1) as an antimicrobial agent against Staphylococcus aureus (S.aureus) and Escherichia coli (E.coli).
EFFECT: effective inhibition of Staphylococcus aureus (S.aureus) and Escherichia coli (E.coli) provided by a low-toxic compound of structure (1).
1 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AMIDE (E)-2-AMINO-4-OXO-5-(2-OXO-2-PHENYLETHYLIDENE)-1-(3-ETHOXYCARBONYL)-4,5,6-7-TETRAHYDROBENZO[B]THIOPHEN-2-YL)4,5-DIHYDRO-1H-PYRROLE-3-CARBOXYLIC ACID, HAVING ANTIMICROBIAL ACTIVITY | 2020 |
|
RU2738405C1 |
| USE OF AN ANALGETIC DRUG BASED ON 2-((6-(4-METHOXYPHENYL)-2-METHYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4(1H)-YLIDENE)AMINO)-4,5,6,7- AMIDE TETRAHYDROBENZO[b]THIOPHENE-3-CARBOXYLIC ACID | 2023 |
|
RU2809054C1 |
| 2-{3-[2-(9H-FLUOREN-9-YLIDENE)HYDRASONO]-5-PHENYL2-2FURANYLIDENE} ACID WITH ANTIMICROBIAL ACTIVITY | 2021 |
|
RU2768759C1 |
| USE OF ETHYL-4-(4-HYDROXY-2-OXO-4-(THIOPHENE-2-YL)BUT-3-ENTHIOAMIDO)BENZOATE FOR TREATMENT OF DISEASES CAUSED BY GOLDEN STAPHYLOCOCCUS | 2022 |
|
RU2785779C1 |
| ANTIBIOTIC DERIVATIVES OF 2-OXO-OXAZOLIDINE-3, 5-DIYL | 2012 |
|
RU2616609C2 |
| PROTEIN TYROSINE KINASE RECEPTOR INHIBITOR COMPOSITIONS | 2009 |
|
RU2586212C2 |
| USE OF N-(2-OXO-6-(3,4,5-TRIMETHOXYPHENYL)-2H-PYRAN-3-YL)BENZAMIDE AS AN ANTI-MICROBIAL AGENT | 2023 |
|
RU2809158C1 |
| 5-PHENYL-2-(3-CYANO-4,5,6,7-TETRAHYDROBENZO[b]THIEN-2-YL)IMINO-2H-FURAN-3-ONE, POSSESSING ANTIMICROBIAL AND ANALGETIC ACTIVITY | 2014 |
|
RU2560521C1 |
| USE OF 4-(4-CHLOROPHENYL)-N-(3-CYANO-4,5,6,7-TETRAHYDROBEZO[b]THIOPHEN-2-YL)-3H-BENZO[b][1,4]DIAZEPINE-2-CARBOXAMIDE AS AN ANTIMICROBIAL AGENT | 2023 |
|
RU2809055C1 |
| ETHYL ETHER OF 2-(((Z)-AMINO((Z)-2,4-DIOXO-5-(2-OXO-2-PHENYLETHYLIDENE)PIRROLIDINE-3-YLIDEN)METHYL)AMINO)-4,5,6,7-TETRAHYDROBENZO[b]THIOPHENCARBOXYLIC ACID WITH ANALGETIC ACTIVITY | 2016 |
|
RU2631649C1 |
